ESSA Pharma
EPIX
EPIX was delisted on the 8th of October, 2025.
10 hedge funds and large institutions have $1.49M invested in ESSA Pharma in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
0.16% more ownership
Funds ownership: 23.56% → 23.72% (+0.16%)
0% more funds holding
Funds holding: 10 → 10 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
21% less capital invested
Capital invested by funds: $1.9M → $1.49M (-$404K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$17.9K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$8.15K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2.15K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$8K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$5.68K |
| 3 |
Morgan Stanley
New York
|
-$2.6K |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$68 |
EPIX Hedge Fund Activity: Q4 2017 in Review
10 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in ESSA Pharma (EPIX) for Q4 2017, worth a combined $1.49M — down 21% from $1.9M a quarter earlier.
Fund positioning in EPIX was balanced in Q4 2017: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $17.9K. The largest seller was Virtu Financial, exiting entirely with an estimated $8K sold.
- 10 institutional investors held ESSA Pharma (EPIX) as of Q4 2017, unchanged from Q3 2017.
- Funds reported $1.49M of ESSA Pharma stock for Q4 2017, down 21% quarter-over-quarter.
- 2 funds opened new ESSA Pharma positions in Q4 2017 and 2 closed out, a net change of 0 holders.
- The largest ESSA Pharma buyer in Q4 2017 was Susquehanna International Group, an estimated $17.9K added.
- The largest ESSA Pharma seller in Q4 2017 was Virtu Financial, an estimated $8K sold.
Based on aggregated 13F filings for Q4 2017.